Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry. Read more

6 Followers on Owler
6 Followers on Owler
6 Followers on Owler
6 Followers on Owler

Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry. Read more

Timothy G. Rothwell's photo - Chairman of Emisphere

Chairman

Timothy G. Rothwell

CEO Approval Rating

90/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Oramed is Emisphere's top competitor. Oramed is headquartered in Jerusalem, Jerusalem District, and was founded in 2006. Like Emisphere, Oramed also operates in the Biotechnology field. Oramed generates ∞% the revenue of Emisphere.

Rani Therapeutics is seen as one of Emisphere's top competitors. Rani Therapeutics's headquarters is in San Jose, California, and was founded in 2012. Like Emisphere, Rani Therapeutics also works within the Biotechnology industry. Rani Therapeutics generates ∞% of Emisphere's revenue.

Enteris has been one of Emisphere's top competitors. Enteris was founded in 2013, and its headquarters is in Boonton, New Jersey. Like Emisphere, Enteris also works within the Biotechnology field. Enteris has 10 fewer employees than Emisphere.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Moderna a competitor of Emisphere?

Acquisitions

No recent acquisitions found related to Emisphere

Emisphere Funding History

No recent funding data found related to Emisphere

Investments

No recent investments found related to Emisphere

Emisphere News

November 16, 2020MarketScreener

EMIS) for Potential Securities Violations and Breach of Fiduciary Duty

(marketscreener.com) Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating ... See more »
November 14, 2020Markets Insider

Monteverde & Associates PC Announces an Investigation of Emisphere Technologies, Inc. - EMIS | Markets Insider

NEW YORK, Nov. 13, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde &... See more »
November 10, 2020PMLiVE

Novo Nordisk set to acquire Emisphere Technology for $1.8bn

Danish pharma will acquire all outstanding shares in Emisphere... See more »
November 9, 2020MarketScreener

Bragar Eagel & Squire, P.C. Investigates Sale of EMIS and Encourages Investors to Contact the Firm

(marketscreener.com) NEW YORK, Nov. 09, 2020 -- Bragar Eagel & Squire, P.C., a nationally recognized ... See more »
November 9, 2020Benzinga

Abraham, Fruchter & Twersky, LLP Is Investigating the Sale of Emisphere and Encourages Investors to Contact the Firm

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nati... See more »
November 6, 2020The Pharma Letter

Major acquisition signals Novo's intent in oral biologics

Danish diabetes giant Novo Nordisk has bought drug delivery company Emisphere Technologies for $1.35.... See more »
November 6, 2020Acquisitions Daily

Novo Nordisk to buy Emisphere Technologies

Danish diabetes drug maker Novo Nordisk is acquiring US Emisphere Technologies, which specialises in ... See more »

Emisphere Press Releases

June 29, 2018StreetInsider

Emisphere Development Update

ROSELAND, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced yesterday the completion and... See more »
May 30, 2018StreetInsider

ELIGEN B12 Receives "Amazon's Choice" Designation

ROSELAND, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today anno... See more »
February 22, 2018streetinsider

Emisphere Development Update

Novo Nordisk announced today the successful completion of the first phase 3a trial, PIONEER 1, with o... See more »
February 22, 2018econotimes

Emisphere Development Update

ROSELAND, N.J., Feb. 22, 2018 -- Novo Nordisk announced today the successful completion of the first ... See more »

Social Media

Headquarters

4 Becker Farm Road Suite 103

Roseland, New Jersey07068

1-973-532-8000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Emisphere is a drug delivery company that develops and commercializes oral therapeutics formulations for the pharmaceutical industry. Emisphere was founded in 1986. Emisphere's headquarters is located in Roseland, New Jersey, USA 07068. Emisphere's C...

CEO

Emisphere's Chairman, Timothy G. Rothwell, currently has an approval rating of 90%. Emisphere's primary competitors are Oramed, Rani Therapeutics & Enteris.

Website

emisphere.com

Frequently Asked Questions about Emisphere

  1. When was Emisphere founded?

    Emisphere was founded in 1986
  2. Who is Emisphere's CEO?

    Emisphere's CEO is Timothy G. Rothwell
  3. How much revenue does Emisphere generate?

    Emisphere generates $ < 1M in revenue
  4. How much funding does Emisphere have?

    Emisphere has historically raised $0 in funding
  1. Where is Emisphere's headquarters?

    Emisphere's headquarters is in Roseland New Jersey, USA
  2. How many employees does Emisphere have?

    Emisphere has 35 employees
  3. What sector does Emisphere operate in?

    Emisphere is in Biotechnology
  4. Who are Emisphere's competitors?

    Emisphere's top competitors are Oramed, Rani Therapeutics, Enteris